Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Deciphering the Heterogeneity of Acute Myeloid Leukemia through Chromatin Accessibility Profiling

Blood (2024) 144 (Supplement 1): 639.

https://doi.org/10.1182/blood-2024-200415

Published: 2024

Journal Articles

Transfusion Patterns during Early Follow-up Predict Overall Survival Independently of IPSS-M in Patients with Myelodysplastic Syndromes

Maria Creignou, Elsa Bernard, Michael Crowther, Anna Tranberg, Elisabeth Ejerblad, Lars Nilsson, Hege Garelius, Petar Antunovic, Bengt Erik Holger Rasmussen, Fryderyk Lorenz, Gabriele Todisco, Gunilla Walldin, Teresa Mortera-Blanco, Monika Jansson, Magnus Tobiasson, Gustaf Edgren, Martin Jadersten, Elli Papaemmanuil, Eva Hellström-Lindberg

Blood (2022) 140 (Supplement 1): 6968–6970.

https://doi.org/10.1182/blood-2022-155811

Published: 2022

Journal Articles

Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period

Gunnar Juliusson, Oskar Hagberg, Vladimir Lj Lazarevic, Emma Ölander, Petar Antunovic, Jörg Cammenga, Lovisa Wennström, Lars Möllgård, Mats Brune, Martin Jädersten, Stefan Deneberg, Sören Lehmann, Åsa Rangert Derolf, Martin Höglund

Blood (2019) 134 (18): 1558–1561.

https://doi.org/10.1182/blood.2019001728

Published: 2019

Includes: Supplemental data

Journal Articles

Prevalence and Characteristics of Survivors from Adult Acute Myeloid Leukemia (AML) in Sweden 2014

Gunnar Juliusson, MD PhD, Vladimir Lazarevic, Petar Antunovic, MD, Asa Rangert Derolf, MDPhD, Hege Garelius, MD, Sören Lehmann, Prof, Kristina Myhr-Eriksson, MD, Lars Möllgård, MDPhD, Bertil Uggla, MDPhD, Anders Wahlin, Prof, Lovisa Wennström, MD PhD, Martin Höglund, Ass Prof

Blood (2015) 126 (23): 4888.

https://doi.org/10.1182/blood.V126.23.4888.4888

Published: 2015

Journal Articles

Reasons for Decreasing Early Mortality in Acute Myeloid Leukemia: An Epidemiological Study from the Swedish Acute Leukemia Registry

Stefan Deneberg, MD, PhD, Ebba Lundin, Vladimir Lazarevic, Lina Benson, Bertil Uggla, MDPhD, Petar Antunovic, MD, Lars Mollgard, Sören Lehmann, Prof, Gunnar Juliusson, MD PhD, Martin Höglund, Ass Prof, Asa Rangert Derolf, MDPhD

Blood (2015) 126 (23): 3748.

https://doi.org/10.1182/blood.V126.23.3748.3748

Published: 2015

Journal Articles

Improved Survival of Patients with Acute Myeloid Leukemia Following Implementation of Swedish National Guidelines: Results from the AML Registry 1997-2013

Gunnar Juliusson, MD PhD, Vladimir Lazarevic, MD, Sören Lehmann, MD PhD, Åsa Rangert Derolf, MD PhD, Lars Möllgård, MDPhD, Hege Garelius, MD, Lovisa Wennström, MD PhD, Bertil Uggla, MD PhD, Petar Antunovic, MD, Kristina Myhr-Eriksson, MD, Anders Wahlin, MD PhD, Martin Höglund, MDPhD

Blood (2014) 124 (21): 2269.

https://doi.org/10.1182/blood.V124.21.2269.2269

Published: 2014

Journal Articles

Allogeneic Transplantation in First Remission Improves Outcome in Secondary Acute Myeloid Leukemia

Christer Nilsson, MD, Erik Hulegårdh, MD, Vladimir Lazarevic, MD, Hege Garelius, MD, Asa Rangert Derolf, MDPhD, Lars Möllgård, MDPhD, Lovisa Wennström, MD PhD, Bertil Uggla, MD PhD, Petar Antunovic, MD, Kristina Myhr-Eriksson, MD, Anders Wahlin, MD PhD, Martin Höglund, MDPhD, Gunnar Juliusson, MD PhD, Dick Stockelberg, MD PhD, Lehmann Soren, MD PhD

Blood (2014) 124 (21): 281.

https://doi.org/10.1182/blood.V124.21.281.281

Published: 2014

Journal Articles

Poor Outcome in Secondary Acute Myeloid Leukemia (AML): A First Report From the Population-Based Swedish Acute Leukemia Registry

Soren Lehmann, MD, PhD, Vladimir Lazarevic, MD, Ann-Sofi Hörstedt, Erik Hulegårdh, MD, Christer Nilsson, MD, Petar Antunovic, MD, Åsa Rangert Derolf, MD, PhD, Lars Möllgård, MD, PhD, Bertil Uggla, MD, PhD, Lovisa Vennström, MD, Anders Wahlin, MD, PhD, Martin Hoglund, MD, PhD, Dick Stockelberg, MD, PhD, Gunnar Juliusson, MD, PhD

Blood (2012) 120 (21): 130.

https://doi.org/10.1182/blood.V120.21.130.130

Published: 2012

Journal Articles

Proportion of Adult AML Patient Population Receiving Allogeneic Stem Cell Transplantation and Long-Term Outcome: Real World Data From the Swedish National Acute Leukemia Registry.

Gunnar Juliusson, Lars Möllgård, Sören Lehmann, MD, PhD, Åsa Rangert Derolf, M.D., Ulf Tidefelt, MD, PhD, Dick Stockelberg, MD, PhD, Mats L Brune, Vladimir Lazarevic, Petar Antunovic, Anders Wahlin, Martin Hoglund, MD, PhD

Blood (2009) 114 (22): 2289.

https://doi.org/10.1182/blood.V114.22.2289.2289

Published: 2009

Journal Articles

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

Gunnar Juliusson, Petar Antunovic, Åsa Derolf, Sören Lehmann, Lars Möllgård, Dick Stockelberg, Ulf Tidefelt, Anders Wahlin, Martin Höglund

Blood (2009) 113 (18): 4179–4187.

https://doi.org/10.1182/blood-2008-07-172007

Published: 2009

Journal Articles

Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndr–ome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy

Michael Grövdal, Rasheed Khan, Anni Aggerholm, Petar Antunovic, Jan Astermark, Per Bernell, Lena-Maria Engström, Lars Kjeldsen, Olle Linder, Lars Nilsson, Anna Olsson, Jonas Wallvik, Jon Magnus Tangen, Gunnar Öberg, Sten Eirik Jacobsen, Anna Porwit, Peter Hokland, Eva Hellström-Lindberg

Blood (2008) 112 (11): 223.

https://doi.org/10.1182/blood.V112.11.223.223

Published: 2008

Journal Articles

Maintenance Treatment with Azacytidine for Patients with High Risk Myelodysplastic Syndromes or Acute Myeloid Leukaemia in Complete Remission after Intensive Chemotherapy.

Michael Grövdal, Rasheed Khan, Anni Aggerholm, Petar Antunovic, Jan Astermark, Per Bernell, Lena-Maria Engström, Lars Kjeldsen, Olle Linder, Lars Nilsson, Anna Olsson, Jonas Wallvik, Jon Magnus Tangen, Gunnar Öberg, Sten Eirik Jacobsen, Peter Hokland, Anna Porwit, Eva Hellström-Lindberg

Blood (2007) 110 (11): 818.

https://doi.org/10.1182/blood.V110.11.818.818

Published: 2007

Journal Articles

The JAK2 V617F Mutation Identifies Specific Subgroups of Myelodysplastic Syndrome (MDS).

Blood (2006) 108 (11): 2610.

https://doi.org/10.1182/blood.V108.11.2610.2610

Published: 2006

Journal Articles

Linkage analysis for major histocompatibility complex–related genetic susceptibility in familial chronic lymphocytic leukemia

Blood (2000) 96 (12): 3982–3984.

https://doi.org/10.1182/blood.V96.12.3982

Published: 2000

NARROW

Deciphering the Heterogeneity of Acute Myeloid Leukemia through Chromatin Accessibility Profiling

Transfusion Patterns during Early Follow-up Predict Overall Survival Independently of IPSS-M in Patients with Myelodysplastic Syndromes

Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period

Prevalence and Characteristics of Survivors from Adult Acute Myeloid Leukemia (AML) in Sweden 2014

Reasons for Decreasing Early Mortality in Acute Myeloid Leukemia: An Epidemiological Study from the Swedish Acute Leukemia Registry

Improved Survival of Patients with Acute Myeloid Leukemia Following Implementation of Swedish National Guidelines: Results from the AML Registry 1997-2013

Allogeneic Transplantation in First Remission Improves Outcome in Secondary Acute Myeloid Leukemia

Poor Outcome in Secondary Acute Myeloid Leukemia (AML): A First Report From the Population-Based Swedish Acute Leukemia Registry

Proportion of Adult AML Patient Population Receiving Allogeneic Stem Cell Transplantation and Long-Term Outcome: Real World Data From the Swedish National Acute Leukemia Registry.

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndr–ome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy

Maintenance Treatment with Azacytidine for Patients with High Risk Myelodysplastic Syndromes or Acute Myeloid Leukaemia in Complete Remission after Intensive Chemotherapy.

The JAK2 V617F Mutation Identifies Specific Subgroups of Myelodysplastic Syndrome (MDS).

Linkage analysis for major histocompatibility complex–related genetic susceptibility in familial chronic lymphocytic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only